ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 86 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,094,000 | -73.4% | 100,665 | -58.2% | 0.11% | -73.3% |
| Q3 2016 | $7,887,000 | -48.8% | 240,665 | -61.0% | 0.42% | -50.8% |
| Q2 2016 | $15,403,000 | +624.2% | 616,865 | +610.1% | 0.85% | +491.6% |
| Q1 2016 | $2,127,000 | -83.5% | 86,865 | -77.7% | 0.14% | -69.1% |
| Q4 2015 | $12,872,000 | +0.8% | 389,700 | 0.0% | 0.46% | +0.7% |
| Q3 2015 | $12,767,000 | -43.3% | 389,700 | -8.3% | 0.46% | -30.6% |
| Q2 2015 | $22,512,000 | +1318.5% | 425,000 | +672.7% | 0.66% | +1441.9% |
| Q1 2015 | $1,587,000 | +4.3% | 55,000 | -54.2% | 0.04% | +7.5% |
| Q3 2014 | $1,522,000 | -24.2% | 120,000 | +20.0% | 0.04% | -33.3% |
| Q2 2014 | $2,007,000 | – | 100,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |